Current Outcome after Surgery for Type A Aortic Dissection.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
01 10 2023
Historique:
medline: 11 9 2023
pubmed: 14 3 2023
entrez: 13 3 2023
Statut: ppublish

Résumé

The aim of this study was to evaluate the outcomes of different surgical strategies for acute Stanford type A aortic dissection (TAAD). The optimal extent of aortic resection during surgery for acute TAAD is controversial. This is a multicenter, retrospective cohort study of patients who underwent surgery for acute TAAD at 18 European hospitals. Out of 3902 consecutive patients, 689 (17.7%) died during the index hospitalization. Among 2855 patients who survived 3 months after surgery, 10-year observed survival was 65.3%, while country-adjusted, age-adjusted, and sex-adjusted expected survival was 81.3%, yielding a relative survival of 80.4%. Among 558 propensity score-matched pairs, total aortic arch replacement increased the risk of in-hospital (21.0% vs. 14.9%, P =0.008) and 10-year mortality (47.1% vs. 40.1%, P =0.001), without decreasing the incidence of distal aortic reoperation (10-year: 8.9% vs. 7.4%, P =0.690) compared with ascending aortic replacement. Among 933 propensity score-matched pairs, in-hospital mortality (18.5% vs. 18.0%, P =0.765), late mortality (at 10-year: 44.6% vs. 41.9%, P =0.824), and cumulative incidence of proximal aortic reoperation (at 10-year: 4.4% vs. 5.9%, P =0.190) after aortic root replacement was comparable to supracoronary aortic replacement. Replacement of the aortic root and aortic arch did not decrease the risk of aortic reoperation in patients with TAAD and should be performed only in the presence of local aortic injury or aneurysm. The relative survival of TAAD patients is poor and suggests that the causes underlying aortic dissection may also impact late mortality despite surgical repair of the dissected aorta.

Sections du résumé

OBJECTIVE
The aim of this study was to evaluate the outcomes of different surgical strategies for acute Stanford type A aortic dissection (TAAD).
SUMMARY BACKGROUND DATA
The optimal extent of aortic resection during surgery for acute TAAD is controversial.
METHODS
This is a multicenter, retrospective cohort study of patients who underwent surgery for acute TAAD at 18 European hospitals.
RESULTS
Out of 3902 consecutive patients, 689 (17.7%) died during the index hospitalization. Among 2855 patients who survived 3 months after surgery, 10-year observed survival was 65.3%, while country-adjusted, age-adjusted, and sex-adjusted expected survival was 81.3%, yielding a relative survival of 80.4%. Among 558 propensity score-matched pairs, total aortic arch replacement increased the risk of in-hospital (21.0% vs. 14.9%, P =0.008) and 10-year mortality (47.1% vs. 40.1%, P =0.001), without decreasing the incidence of distal aortic reoperation (10-year: 8.9% vs. 7.4%, P =0.690) compared with ascending aortic replacement. Among 933 propensity score-matched pairs, in-hospital mortality (18.5% vs. 18.0%, P =0.765), late mortality (at 10-year: 44.6% vs. 41.9%, P =0.824), and cumulative incidence of proximal aortic reoperation (at 10-year: 4.4% vs. 5.9%, P =0.190) after aortic root replacement was comparable to supracoronary aortic replacement.
CONCLUSIONS
Replacement of the aortic root and aortic arch did not decrease the risk of aortic reoperation in patients with TAAD and should be performed only in the presence of local aortic injury or aneurysm. The relative survival of TAAD patients is poor and suggests that the causes underlying aortic dissection may also impact late mortality despite surgical repair of the dissected aorta.

Identifiants

pubmed: 36912033
doi: 10.1097/SLA.0000000000005840
pii: 00000658-990000000-00398
doi:

Substances chimiques

1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose 80321-89-7

Banques de données

ClinicalTrials.gov
['NCT04831073']

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e885-e892

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Références

Benedetto U, Dimagli A, Kaura A, et al. Determinants of outcomes following surgery for type A acute aortic dissection: the UK National Adult Cardiac Surgical Audit. Eur Heart J. 2021;43:44–52.
Larsen M, Trimarchi S, Patel HJ, et al. Extended versus limited arch replacement in acute type A aortic dissection. Eur J Cardiothorac Surg. 2017;52:1104–1110.
Czerny M, Schmidli J, Adler S, et al. Current options and recommendations for the treatment of thoracic aortic pathologies involving the aortic arch: an expert consensus document of the European Association for Cardio-Thoracic surgery (EACTS) and the European Society for Vascular Surgery (ESVS). Eur J Cardiothorac Surg. 2019;55:133–162.
Sá MP, Jacquemyn X, Tasoudis PT, et al. Long-term outcomes of total arch replacement versus proximal aortic replacement in acute type A aortic dissection: Meta-analysis of Kaplan-Meier-derived individual patient data. J Card Surg. 2022;37:4256–4266.
Heuts S, Adriaans BP, Kawczynski MJ, et al. Extending aortic replacement beyond the proximal arch in acute type A aortic dissection: a meta-analysis of short term outcomes and long term actuarial survival. Eur J Vasc Endovasc Surg. 2022;63:674–687.
Bachet J. Commentary: Surgery of acute type A aortic dissection: Are we appropriately managing the aortic root. J Thorac Cardiovasc Surg. 2022;163:912–913.
Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12:e1001885.
von Elm E, Altman DG, Egger M, et al. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–349.
Biancari F, Mariscalco G, Yusuff H, et al. European registry of type A aortic dissection (ERTAAD) - rationale, design and definition criteria. J Cardiothorac Surg. 2021;16:171.
Human Mortality Database. Accessed on August 29, 2022. Avialable at https://www.mortality.org/
Heinemann M, Laas J, Karck M, et al. Thoracic aortic aneurysms after acute type A aortic dissection: necessity for follow-up. Ann Thorac Surg. 1990;49:580–584.
Heinemann M, Laas J, Jurmann M, et al. Surgery extended into the aortic arch in acute type A dissection. Indications, techniques, and results. Circulation. 1991;84(5 suppl):III25–III30.
Yun KL, Glower DD, Miller DC, et al. Aortic dissection resulting from tear of transverse arch: is concomitant arch repair warranted? J Thorac Cardiovasc Surg. 1991;102:355–368.
Crawford ES, Kirklin JW, Naftel DC, et al. Surgery for acute dissection of ascending aorta. Should the arch be included? J Thorac Cardiovasc Surg. 1992;104:46–59.
Bachet J, Teodori G, Goudot B, et al. Replacement of the transverse aortic arch during emergency operations for type A acute aortic dissection. Report of 26 cases. J Thorac Cardiovasc Surg. 1988;96:878–886.
Bojko MM, Assi R, Bavaria JE, et al. Midterm outcomes and durability of sinus segment preservation compared with root replacement for acute type A aortic dissection. J Thorac Cardiovasc Surg. 2022;163:900–910.e2.
Pan E, Gudbjartsson T, Ahlsson A, et al. Low rate of reoperations after acute type A aortic dissection repair from The Nordic Consortium Registry. J Thorac Cardiovasc Surg. 2018;156:939–948.
Yang B, Norton EL, Shih T, et al. Late outcomes of strategic arch resection in acute type A aortic dissection. J Thorac Cardiovasc Surg. 2019;157:1313–1321.e2.

Auteurs

Fausto Biancari (F)

Heart and Lung Center, Helsinki University Hospital, Helsinki.
Department of Medicine, South-Karelia Central Hospital, University of Helsinki, Lappeenranta.

Tatu Juvonen (T)

Heart and Lung Center, Helsinki University Hospital, Helsinki.
Research Unit of Surgery, Anesthesia and Critical Care, University of Oulu, Oulu, Finland.

Antonio Fiore (A)

Department of Cardiac Surgery.

Andrea Perrotti (A)

Department of Thoracic and Cardiovascular Surgery, University of Franche-Comte, Besancon.

Amélie Hervé (A)

Department of Thoracic and Cardiovascular Surgery, University of Franche-Comte, Besancon.

Joseph Touma (J)

Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris.

Matteo Pettinari (M)

Department of Cardiac Surgery, Ziekenhuis Oost Limburg, Genk, Belgium.

Sven Peterss (S)

LMU University Hospital, Ludwig Maximilian University.
German Centre for Cardiovascular Research, Partner Site Munich Heart Alliance, Munich.

Joscha Buech (J)

LMU University Hospital, Ludwig Maximilian University.

Angelo M Dell'Aquila (AM)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster.

Konrad Wisniewski (K)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster.

Andreas Rukosujew (A)

Department of Cardiothoracic Surgery, University Hospital Muenster, Muenster.

Till Demal (T)

Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Hamburg, Germany.

Lenard Conradi (L)

Department of Cardiovascular Surgery, University Heart & Vascular Center Hamburg, Hamburg, Germany.

Marek Pol (M)

Department of Cardiac Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Petr Kacer (P)

Department of Cardiac Surgery, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.

Francesco Onorati (F)

Division of Cardiac Surgery, University of Verona Medical School, Verona.

Cecilia Rossetti (C)

Division of Cardiac Surgery, University of Verona Medical School, Verona.

Igor Vendramin (I)

Cardiothoracic Department, University Hospital, Udine.

Daniela Piani (D)

Cardiothoracic Department, University Hospital, Udine.

Mauro Rinaldi (M)

Cardiac Surgery, Molinette Hospital, University of Turin, Turin.

Luisa Ferrante (L)

Cardiac Surgery, Molinette Hospital, University of Turin, Turin.

Eduard Quintana (E)

Department of Cardiovascular Surgery, Hospital Clínic de Barcelona, University of Barcelona, Spain.

Robert Pruna-Guillen (R)

Department of Cardiovascular Surgery, Hospital Clínic de Barcelona, University of Barcelona, Spain.

Javier Rodriguez Lega (J)

Cardiovascular Surgery Department, University Hospital Gregorio Marañón, Madrid, Spain.

Angel G Pinto (AG)

Cardiovascular Surgery Department, University Hospital Gregorio Marañón, Madrid, Spain.

Metesh Acharya (M)

Department of Cardiac Surgery, Glenfield Hospital, Leicester.

Zein El-Dean (Z)

Department of Cardiac Surgery, Glenfield Hospital, Leicester.

Mark Field (M)

Liverpool Centre for Cardiovascular Sciences, Liverpool Heart and Chest Hospital, Liverpool, UK.

Amer Harky (A)

Liverpool Centre for Cardiovascular Sciences, Liverpool Heart and Chest Hospital, Liverpool, UK.

Francesco Nappi (F)

Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris.

Sebastien Gerelli (S)

Centre Hospitalier Annecy Genevois, France.

Dario Di Perna (D)

Centre Hospitalier Annecy Genevois, France.

Giuseppe Gatti (G)

Division of Cardiac Surgery, Cardiothoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste.

Enzo Mazzaro (E)

Division of Cardiac Surgery, Cardiothoracic and Vascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste.

Stefano Rosato (S)

Center for Global Health, National Health Institute, Rome, Italy.

Peter Raivio (P)

Heart and Lung Center, Helsinki University Hospital, Helsinki.

Mikko Jormalainen (M)

Heart and Lung Center, Helsinki University Hospital, Helsinki.

Giovanni Mariscalco (G)

Department of Cardiac Surgery, Glenfield Hospital, Leicester.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH